Summary
Synopsys, Inc. (SNPS) filed its 10-K for the fiscal year ended October 31, 2000, showcasing its position as a leading provider of Electronic Design Automation (EDA) software. The company's products are crucial for the design, verification, and testing of integrated circuits (ICs), enabling customers to accelerate time-to-market for complex electronic products. Significant strategic shifts were noted, including the introduction of Technology Subscription Licenses (TSLs) aimed at improving revenue visibility and customer alignment, although this transition impacted reported revenue in the short term. The company is heavily investing in Research and Development, particularly in areas like physical synthesis and verification, to address critical industry challenges such as timing closure and the designer shortage. Financially, Synopsys reported total revenue of $783.8 million for fiscal year 2000. While overall revenue saw a slight decrease of 3% compared to the prior year, this was largely attributed to the revenue recognition changes associated with the new TSL model. The company's strong international presence is a key factor, with international sales accounting for 42% of total revenue. The market value of non-affiliates' stock as of January 2, 2001, was approximately $2.3 billion, indicating significant market capitalization. Management expressed confidence in their ability to meet working capital requirements, supported by current cash reserves and operational cash flow.
Key Highlights
- 1Synopsys is a leading Electronic Design Automation (EDA) software supplier crucial for IC design, verification, and testing.
- 2The company reported total revenue of $783.8 million for the fiscal year ended October 31, 2000.
- 3A strategic shift to Technology Subscription Licenses (TSLs) was implemented, impacting short-term revenue recognition but aiming for long-term benefits like increased revenue visibility.
- 4Significant investment in R&D (24% of revenue) is focused on physical synthesis, verification, and IP to address industry challenges.
- 5International sales represented a substantial 42% of total revenue, highlighting global reach.
- 6The company's market value of non-affiliates' stock was approximately $2.3 billion as of January 2, 2001.
- 7Synopsys actively supports industry standards and collaborates with major players in the EDA ecosystem.